Business Context and Reporting Period
This Form 8-K was filed by SANUWAVE Health, Inc. on May 6, 2015. The report covers the Company's financial results for the three months ended March 31, 2015, and provides a business update regarding the dermaPACE clinical trial.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.2) and management remarks (Exhibit 99.3), which are incorporated by reference but not detailed in the body of this 8-K.
Material Changes and Updates
- Clinical Trial Update: The Company provided an update on the dermaPACE clinical trial on May 6, 2015.
- Financial Results: The Company announced its first-quarter financial results for the period ended March 31, 2015.
Guidance, Outlook, and Risks
Management hosted a conference call on May 7, 2015, to discuss the financial results and provide a business update. The filing text does not contain specific guidance, risk factors, or contingency details; these are referenced as being available in the attached exhibits.
Investor Verification Checklist
- Review Exhibit 99.2 for specific Q1 2015 revenue, net loss, and cash position figures.
- Examine Exhibit 99.1 for detailed outcomes and timelines regarding the dermaPACE clinical trial.
- Listen to the conference call or read Exhibit 99.3 for management's commentary on future operational plans and liquidity needs.